Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04219254
Title A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioInvent International AB
Indications

melanoma

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

BI-1206 + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute Recruiting Denver Colorado 80218 United States Details
HealthPartners Institute - Regions Cancer Care Center, Recruiting Saint Paul Minnesota 55101 United States Details
Oklahoma University , Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
NEXT Oncology Recruiting San Antonio Texas 78229 United States Details
Sahlgrenska University Hospital Recruiting Göteborg Sweden Details
Lund University Hospital Recruiting Lund Sweden Details
Karolinska University Hospital, Solna Recruiting Stockholm Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field